Cart
sales@molnova.com
Praluzatamab
CAS No. 2145109-70-0
Praluzatamab( —— )
Catalog No. M36824 CAS No. 2145109-70-0
Praluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 534 | In Stock |
|
| 10MG | 825 | In Stock |
|
| 25MG | 1216 | In Stock |
|
| 50MG | 1609 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePraluzatamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPraluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116).
-
DescriptionPraluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorADC Antibody
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2145109-70-0
-
Formula WeightApproximately 146.9 kDa.
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martín-Sabroso C, et al. Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics. 2021 Oct 15;13(10):1705. ?
molnova catalog
related products
-
Kobophenol A
Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death.
-
3′,5′-Dimethoxyaceto...
3′,5′-Dimethoxyacetophenone is a natural product from Scrophularia buergeriana with antioxidant activities.
-
Lys-(Des-Arg9,Leu8)-...
Lys-(Des-Arg9,Leu8)-Bradykinin is a bradykinin B1 receptor antagonist.
